| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Department of Gene Regulation, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan
We reported previously that activation of endogenous activator protein 1 (AP-1) in chicken embryo fibroblasts is essential for the cellular transformation induced by v-src, and we further showed that the activation of AP-1 is accompanied by elevation of Fra-2 and c-Jun expression and also high-level phosphorylation of Fra-2 by activated endogenous extracellular signal-regulated kinase [mitogen-activated protein kinase (MAPK)]. Here, we report that the transcriptional activity of Fra-2/c-Jun heterodimer was greatly enhanced by cotransfecting a constitutively active mutant of MEK1 gene (MEK-DD) into F9 cells, indicating that Fra-2 was converted into an active transactivator after phosphorylation by MAPK. High-level expression of MEK-DD alone was sufficient to induce clear cellular transformation of chicken embryo fibroblasts, which caused constitutive activation of endogenous MAPK, hyperphosphorylation of Fra-2, and elevation of fra-2 and c-jun gene expression. These results indicate that phosphorylation of Fra-2 by MAPK plays an important role in stimulating endogenous AP-1 activity in a positive autoregulation mechanism, in which phosphorylated Fra-2 induces fra-2 expression through AP-1 binding sites present in its promoter. We also localized the Fra-2 phosphorylation sites by MAPK to three threonine and three serine residues in the COOH-terminal region by means of site-directed mutagenesis and showed that the threonine residues were more susceptible to MAPK.
This article has been cited by other articles:
![]() |
H. Rangaswami, N. Marathe, S. Zhuang, Y. Chen, J.-C. Yeh, J. A. Frangos, G. R. Boss, and R. B. Pilz Type II cGMP-dependent Protein Kinase Mediates Osteoblast Mechanotransduction J. Biol. Chem., May 29, 2009; 284(22): 14796 - 14808. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lamirand, S. Pallud-Mothre, M. Ramauge, M. Pierre, and F. Courtin Oxidative Stress Regulates Type 3 Deiodinase and Type 2 Deiodinase in Cultured Rat Astrocytes Endocrinology, July 1, 2008; 149(7): 3713 - 3721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Hanai, T. Mammoto, P. Seth, K. Mori, S. A. Karumanchi, J. Barasch, and V. P. Sukhatme Lipocalin 2 Diminishes Invasiveness and Metastasis of Ras-transformed Cells J. Biol. Chem., April 8, 2005; 280(14): 13641 - 13647. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Mitchell and S. J. Lye Differential Activation of the Connexin 43 Promoter by Dimers of Activator Protein-1 Transcription Factors in Myometrial Cells Endocrinology, April 1, 2005; 146(4): 2048 - 2054. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chang, A. Rewari, M. Centrella, and T. L. McCarthy Fos-related Antigen 2 Controls Protein Kinase A-induced CCAAT/Enhancer-binding Protein {beta} Expression in Osteoblasts J. Biol. Chem., October 8, 2004; 279(41): 42438 - 42444. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gensch, M. Gallup, A. Sucher, D. Li, A. Gebremichael, H. Lemjabbar, A. Mengistab, V. Dasari, J. Hotchkiss, J. Harkema, et al. Tobacco Smoke Control of Mucin Production in Lung Cells Requires Oxygen Radicals AP-1 and JNK J. Biol. Chem., September 10, 2004; 279(37): 39085 - 39093. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Holloway, S. Murthy, and D. El-Ashry A Cytoplasmic Substrate of Mitogen-Activated Protein Kinase Is Responsible for Estrogen Receptor-{alpha} Down-Regulation in Breast Cancer Cells: The Role of Nuclear Factor-{kappa}B Mol. Endocrinol., June 1, 2004; 18(6): 1396 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Raucci, E. Laplantine, A. Mansukhani, and C. Basilico Activation of the ERK1/2 and p38 Mitogen-activated Protein Kinase Pathways Mediates Fibroblast Growth Factor-induced Growth Arrest of Chondrocytes J. Biol. Chem., January 16, 2004; 279(3): 1747 - 1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. O. Murphy, J. P. MacKeigan, and J. Blenis A Network of Immediate Early Gene Products Propagates Subtle Differences in Mitogen-Activated Protein Kinase Signal Amplitude and Duration Mol. Cell. Biol., January 1, 2004; 24(1): 144 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Casalino, D. De Cesare, and P. Verde Accumulation of Fra-1 in ras-Transformed Cells Depends on Both Transcriptional Autoregulation and MEK-Dependent Posttranslational Stabilization Mol. Cell. Biol., June 15, 2003; 23(12): 4401 - 4415. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Pursiheimo, J. Saari, M. Jalkanen, and M. Salmivirta Cooperation of Protein Kinase A and Ras/ERK Signaling Pathways Is Required for AP-1-mediated Activation of Fibroblast Growth Factor-inducible Response Element (FiRE) J. Biol. Chem., July 5, 2002; 277(28): 25344 - 25355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eriksson and S. Leppa Mitogen-activated Protein Kinases and Activator Protein 1 Are Required for Proliferation and Cardiomyocyte Differentiation of P19 Embryonal Carcinoma Cells J. Biol. Chem., May 3, 2002; 277(18): 15992 - 16001. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Young, R. Nair, N. Bucheimer, P. Tulsian, N. Brown, C. Chapp, T.-C. Hsu, and N. H. Colburn Transactivation of Fra-1 and Consequent Activation of AP-1 Occur Extracellular Signal-Regulated Kinase Dependently Mol. Cell. Biol., January 15, 2002; 22(2): 587 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Smith, Z. Burke, A. Humphries, T. Wells, D. Klein, D. Carter, and R. Baler Tissue-Specific Transgenic Knockdown of Fos-Related Antigen 2 (Fra-2) Expression Mediated by Dominant Negative Fra-2 Mol. Cell. Biol., June 1, 2001; 21(11): 3704 - 3713. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Watanabe, C. A. Kessler, C. J. Bachurski, Y. Kanda, B. D. Richardson, J. Stanek, S. Handwerger, and A. K. Brar Identification of a Decidua-Specific Enhancer on the Human Prolactin Gene with Two Critical Activator Protein 1 (AP-1) Binding Sites Mol. Endocrinol., April 1, 2001; 15(4): 638 - 653. [Abstract] [Full Text] |
||||
![]() |
V. Boss, J. D. Roback, A. N. Young, L. J. Roback, D. M. V. Weisenhorn, R. Medina-Flores, and B. H. Wainer Nerve Growth Factor, But Not Epidermal Growth Factor, Increases Fra-2 Expression and Alters Fra-2/JunD Binding to AP-1 and CREB Binding Elements in Pheochromocytoma (PC12) Cells J. Neurosci., January 1, 2001; 21(1): 18 - 26. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |